AI at Moderna
Moderna is a Cambridge, Massachusetts-based biotechnology company that has built its operating model around messenger RNA (mRNA), a technology it has…
•
In-Depth Analysis
Consistent coverage of emerging AI capabilities across sectors.
Life Sciences
Latest Coverage of AI in Life Sciences
Closing the Execution Gap in Pharma’s Commercial Model
This article is sponsored by ODAIA and was written, edited, and published in alignment with our Emerj sponsored content guidelines. Learn…
•
Rethinking Clinical Trials with Faster AI-Driven Decision Making
Drug development remains one of the most capital-intensive activities in life sciences. A 2021 peer-reviewed study published in Clinical and Translational…
•
Accelerating Speed to Value through Agentic Systems and Intelligent Automation in Life Sciences
Life sciences enterprises are caught in a widening gap. The pace of R&D, manufacturing, and data-driven decision-making is accelerating, but the…
•
Challenges HR Leaders Face in Adopting Enterprise AI
Talent data fragmentation has emerged as a foundational constraint on enterprise HR’s ability to make strategic workforce decisions, persisting because organizations…
•
Building AI-ready Cultures in Life Sciences R&D
Life sciences are over‑funding AI and under‑funding the data maturity required to scale it. This imbalance is turning a potential R&D…
•
Rethinking How Life Sciences Organizations Approach AI – Mathias Cousin of Deloitte
This interview analysis is sponsored by Deloitte and was written, edited, and published in alignment with our Emerj sponsored content guidelines.…
•
